Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs.

Details

Ressource 1Download: 1-s2.0-S2059702922003830-main.pdf (613.23 [Ko])
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
Serval ID
serval:BIB_B9A4F5D5E104
Type
Article: article from journal or magazin.
Publication sub-type
Editorial
Collection
Publications
Institution
UNIL/CHUV
Title
Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs.
Journal
ESMO open
Author(s)
Overbeek J.K., Heine R.T., Verheul HMW, Chatelut E., Rudek M.A., Gurney H., Plummer R., Gilbert D.C., Buclin T., Burger D.M., Bloemendal H.J., van Erp N.P.
ISSN
2059-7029 (Electronic)
ISSN-L
2059-7029
Publication state
Published
Issued date
02/2023
Peer-reviewed
Oui
Volume
8
Number
1
Pages
100749
Language
english
Notes
Publication types: Editorial ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Keywords
Humans, Off-Label Use, Antineoplastic Agents/therapeutic use, Clinical Protocols
URN
urn:nbn:ch:serval-BIB_B9A4F5D5E1045
OAI-PMH
oai:serval.unil.ch:BIB_B9A4F5D5E104
DOI
10.1016/j.esmoop.2022.100749
Pubmed
36603522
Web of science
001027919900001
Open Access
Yes
Create date
17/01/2023 15:23
Last modification date
08/08/2023 5:57
Usage data